Evidence that 17alpha-estradiol is biologically active in the uterine tissue: Antiuterotonic and antiuterotrophic action

Reproductive Biology and Endocrinology

Volumn 3, Issue , 2005, Pages

  Perusquía, Mercedes ^a   Navarrete, Erika ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ANTIESTROGEN; CALCIUM; CALCIUM ION; CYCLOHEXIMIDE; DACTINOMYCIN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; POTASSIUM CHLORIDE; PROPRANOLOL; TAMOXIFEN; UTERUS SPASMOLYTIC AGENT; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM CHLORIDE; DRUG DERIVATIVE; ESTROGEN; NORADRENALIN;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; FEMALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OVARIECTOMY; RAT; UTERUS CONTRACTILITY; UTERUS CONTRACTION; UTERUS GROWTH; UTERUS RELAXATION; UTERUS WEIGHT; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; HISTOLOGY; IN VITRO STUDY; MUSCLE RELAXATION; PHYSIOLOGY; STEREOISOMERISM; UTERUS; WISTAR RAT;

ANIMALIA;

ANIMALS; CALCIUM CHLORIDE; CYCLOHEXIMIDE; DACTINOMYCIN; ESTRADIOL; ESTROGENS; FEMALE; MUSCLE RELAXATION; NOREPINEPHRINE; POTASSIUM CHLORIDE; PROPRANOLOL; RATS; RATS, WISTAR; STEREOISOMERISM; TAMOXIFEN; UTERINE CONTRACTION; UTERUS;

EID: 27344431896     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-3-30     Document Type: Article

References (51)

1. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC: 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992, 89:883-891.
2. 2α mediated contraction of the porcine coronary artery. Adv Prostaglandin Thromboxane Leukot Res 1989, 19:277-280.
3. Pietras RJ, Szego CM: Estrogen receptors in uterine plasma membrane. J Steroid Biochem 1979, 11:1471-1483.
4. Merriam GR, MacLusky NJ, Johnson LA, Naftolin F: 2-Hydroxyestradiol-17α and 4-hydroxyestradiol-17α, catechol estrogen analogs with reduced estrogen receptor affinity. Steroids 1980, 36:13-20.
5. Schwartz Z, Soskolne WA, Neubauer T, Goldstein M, Adi S, Ornoy A: Direct and sex-specific enhancement of bone formation and calcification by sex-steroids in fetal mice long bone in vitro (biochemical and morphometric study). Endocrinology 1991, 129:1167-1174.
6. Nasatzky E, Schwartz Z, Boyan BD, Soskolne WA, Ornoy A: Sex dependent effects of 17-beta-estradiol on chondrocyte differentiation in culture. J Cell Physiol 1993, 154:359-367.
7. Lundeen SG, Carver JM, McKean ML, Winneker RC: Characterization of ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 1997, 138:1552-1558.
8. Hajek RA, Robertson AD, Johnston DA, Van NT, Tcholakian RK, Wagner LA, Conti CJ, Meistrich ML, Contreras N, Edwards CL, Jones LA: During development, 17alpha-estradiol is a potent estrogen and carcinogen. Environ Health Perspect 1997, 3:577-581.
9. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka N, Takatsuki M: Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 2002, 170:21-30.
10. Yamasaki K, Takeyoshi M, Sawaki M, Imatanaka N, Shinoda K, Takatsuki M: Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. Toxicology 2003, 183:93-115.
11. Fujimoto N, Honda H, Kitamura S: Effects of environmental estrogenic chemicals on API mediated transcription with estrogen receptors α and β. J Steroid Biochem Mol Biol 2004, 88:53-59.
12. Green PS, Bishop J, Simpkins JW: 17α-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neorosci 1997, 17:511-515.
13. Dicko A, Morissette M, Ben Ameur S, Pezolet M, Di Paolo T: Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy. Brain Res Bull 1999, 49:401-405.
14. Morin C, Zini R, Simon N, Tillement JP: Dehydroepiandrosterone and α-estradiol limit the functional alterations of rat brain mitochondria submitted to different experimental stress. Neuroscience 2002, 115:415-424.
15. Salas E, López MG, Villarroya M, Sánchez-García P, De Pascua R, Dixon WR, García AG: Endothelium-independent relaxation by 17-α-estradiol of pig coronary arteries. Eur J Pharmacol 1994, 258:47-55.
16. Rodríguez J, García de Boto MJ, Hidalgo A: Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci 1996, 58:607-615.
17. Seeger H, Mueck AO, Ottel M, Schwarz S, Lippert TH: Calcium antagonistic effect of 17 alpha-estradiol derivatives: in vitro examinations. Gynecol Endocrinol 1999, 13:246-248.
18. Gutiérrez M, Fernández AI, Revuelta MP, Cantabrana B, Hidalgo A: Partial contribution to the relaxant effect of 17α-estradiol in rat uterine smooth muscle. Gen Pharmacol 1998, 30:71-77.
19. Ratz PH, McCammon KA, Altstatt D, Blackmore PF, Shenfeld OZ, Schlossberg SM: Differential effects of sex hormones and phytoestrogens on peack and steady state contractions in isolated rabbit detrusor. J Urol 1999, 162:1821-1828.
20. Sievernich A, Wildt L, Lichtenberg-Frate H: In vitro bioactivity of 17α-estradiol. J Steroid Biochem Mol Biol 2004, 92:455-463.
21. Hobe G, Schon R, Goncharov N, Katsiya G, Koryakin M, Gesson-Cholat I, Oettel M, Zimmermann H: Some new aspects of 17α-estradiol metabolism in man. Steroids 2002, 67:883-893.
22. Bhavnani BR: Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol 2003, 85:473-482.
23. Perusquía M, Hernández R, Kubli-Garfias C: Epitestosterone induces testosterone-like uterine relaxation [abstract]. 10th International Congress of Endocrinology 1996, 549:578.
24. Nuck BA, Lucky AW: Epitestosterone: a potential new antiandrogen. J Invest Dermatol 1987, 89:209-211.
25. Starká I, Bicíková M, Hampl R: Epitestosterone -an endogenous antiandrogen? J Steroid Biochem 1989, 33:1019-1021.
26. Bicíková M, Hampl R, Starká L: Epitestosterone a potent competitive inhibitor of C21-steroid side chain cleavage in testis. J Steroid Biochem Mol Biol 1992, 43:721-724.
27. Lictchfield JT, Wilcoxon FA: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949, 96:99-108.
28. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
29. Perusquía M: Nongenomic action of steroids in myometrial contractility. Endocrine 2001, 15:63-72.
30. Perusquía M, Jasso-Kamel J: Influence of 5α- and 5β-reduced progestins on the contractility of isolated human myometrium at term. Life Sci 2001, 68:2933-2944.
31. Perusquía M, Navarrete E, Jasso-Kamel J, Montaño LM: Androgens induce relaxation of contractile activity in pregnant human myometrium at term: a nongenomic action on L-type calcium channels. Biol Reprod 2005. 10.1095/biolreprod.104.036954
32. Perusquía M, García-Yañez E, Ibáñez R, Kubli-Garfias C: Non-genomic mechanism of action of Δ4 and 5-reduced androgens and progestins on the contractility of isolated rat myometrium. Life Sci 1990, 47:1547-1553.
33. 2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta. Eur J Pharmacol 1999, 371:169-178.
34. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA: Cardiovascular protection by oestrogen -a calcium antagonist effect? Lancet 1993, 341:1264-1265.
35. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992, 106:739-745.
36. 2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994, 266:C975-C980.
37. Pappas TC, Gametchu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 1995, 9:404-410.
38. Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 1999, 13:307-319.
39. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW: ERβ has nongenomic action in caveolae. Mol Endocrinol 2002, 16:938-946.
40. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER: Plasma membrane estrogen receptors exist and function as dimmers. Mol Endocrinol 2004, 18:2854-2865.
41. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM: Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 2001, 14:280-294.
42. Agarwal AK, Bindal RD: Estrogen receptor-binding affinity of tamoxifen analogs with various side chains and their biologic profile in immature rat uterus. Steroids 1991, 56:486-489.
43. Lipton A, Vinijsanum A, Martin L: Acute inhibition of rat myometrial responses to oxytocin by tamoxifen stereoisomers and oestradiol. J Endocrinol 1984, 103:383-388.
44. Fernández AI, Cantabrana B, Hidalgo A: Estrogen and antiestrogen non-genomic effect in rat uterus contraction in calcium-free solution. Gen Pharmacol 1993, 24:391-395.
45. Kostrzewska A, Laudanski T, Batra S: Potent inhibition by tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries. Am J Obstet Gynecol 1997, 176:381-386.
46. Altan N, Chen Y, Schindler M, Simon SM: Tamoxifen inhibits acidification in cells independent of estrogen receptor. Proc Natl Acad Sci 1999, 96:4432-4437.
47. Korach KS: Insights from the study of animals lacking functional estrogen receptor. Science 1994, 266:1524-1527.
48. Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist: activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997, 11:657-666.
49. McDonnell DP: The molecular pharmacology of SERMs. Trends Endocrinol Metab 1999, 10:301-311.
50. Levin ER: Integration of the extra-nuclear and nuclear actions of estrogen. Mol Endocrinol 2005. 10.12107me.2004-0390
51. Zhang H, McElrath T, Tong W, Pollard JW: The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol 2005, 184:129-140.